Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.

Pullarkat ST, Vardiman JW, Slovak ML, Rao DS, Rao NP, Bedell V, Said JW.

Leuk Res. 2008 Nov;32(11):1770-5. doi: 10.1016/j.leukres.2008.02.025. Epub 2008 Apr 15.

PMID:
18417213
2.

Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.

Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.

Cancer Genet Cytogenet. 2008 Jan 1;180(1):60-4.

PMID:
18068536
3.

Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia.

Al-Shehri A, Al-Seraihy A, Owaidah TM, Belgaumi AF.

Hematol Oncol Stem Cell Ther. 2010;3(1):42-6.

4.

Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).

Jarmuz M, Kroll R, Przybyłowicz-Chalecka A, Ratajczak B, Gniot M, Szyfter K, Komarnicki M.

Cancer Genet Cytogenet. 2010 May;199(1):45-7. doi: 10.1016/j.cancergencyto.2010.01.017.

PMID:
20417868
6.

Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.

Ganessan K, Goel R, Kumar K, Bakhshi S.

Pediatr Hematol Oncol. 2007 Apr-May;24(3):195-8.

PMID:
17454789
7.

Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.

Manley R, Cochrane J, McDonald M, Rigby S, Moore A, Kirk A, Clarke S, Crossen PE, Morris CM, Patton WN.

Leukemia. 1999 Jan;13(1):126-9.

PMID:
10049047
8.

Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.

Gaiger A, Henn T, Hörth E, Geissler K, Mitterbauer G, Maier-Dobersberger T, Greinix H, Mannhalter C, Haas OA, Lechner K, Lion T.

Blood. 1995 Sep 15;86(6):2371-8.

9.

Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.

Morris CM.

Methods Mol Biol. 2011;730:33-61. doi: 10.1007/978-1-61779-074-4_4.

PMID:
21431633
10.

t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.

Yin CC, Medeiros LJ, Glassman AB, Lin P.

Am J Clin Pathol. 2004 Jun;121(6):836-42.

PMID:
15198355
11.

A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.

Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.

Genes Chromosomes Cancer. 2003 Jul;37(3):291-9.

PMID:
12759927
12.

Concurrent megakaryocytic and erythroid chronic myelogenous leukemia blast crisis.

Westfall DE, Zhang L, Song S, Lee S.

Arch Pathol Lab Med. 2008 Jun;132(6):1021-5. doi: 10.1043/1543-2165(2008)132[1021:CMAECM]2.0.CO;2.

PMID:
18517263
13.

Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.

Metzke-Heidemann S, Harder L, Gesk S, Schoch R, Jenisch S, Grote W, Siebert R, Schlegelberger B.

Genes Chromosomes Cancer. 2001 May;31(1):10-4.

PMID:
11284030
14.

Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.

Kroschinsky F, Friedrich K, Hanel M, Mohr B, Langer T, Meinhardt M, Thiede C, Bornhauser M, Baretton G, Ehninger G.

Ann Hematol. 2003 Jan;82(1):47-52. Epub 2002 Nov 29.

PMID:
12574966
15.

A case of chronic myelogenous leukemia with T lymphoblastic and megakaryoblastic mixed crisis.

Iwamasa K, Yasukawa M, Fujita S.

Jpn J Med. 1989 Jan-Feb;28(1):89-95.

16.

Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts.

Yamaguchi H, Inokuchi K, Shinohara T, Dan K.

Cancer Genet Cytogenet. 1998 Apr 1;102(1):74-7.

PMID:
9530344
17.

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G.

Blood. 2009 Sep 3;114(10):2159-67. doi: 10.1182/blood-2008-08-173963. Epub 2009 Jul 9. Erratum in: Blood. 2010 Sep 23;116(12):2196.

18.

Fluorescent in situ hybridization diagnosis of extramedullary nodal blast crisis.

Jin GN, Zou P, Chen WX, Ding ZY, Zhou H.

Diagn Cytopathol. 2013 Mar;41(3):253-6. doi: 10.1002/dc.21795. Epub 2011 Aug 26.

PMID:
23417967
19.

ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.

Asimakopoulos FA, Shteper PJ, Krichevsky S, Fibach E, Polliack A, Rachmilewitz E, Ben-Neriah Y, Ben-Yehuda D.

Blood. 1999 Oct 1;94(7):2452-60.

20.

Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.

Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa Si, Ishikawa T, Yazaki Y, Hirai H.

Blood. 2000 Feb 15;95(4):1144-50.

Supplemental Content

Support Center